171 related articles for article (PubMed ID: 8649703)
1. Down syndrome screening in an Asian population using alpha-fetoprotein and free beta-hCG: a report of the Taiwan Down Syndrome Screening Group.
Hsu JJ; Hsieh TT; Hsieh FJ
Obstet Gynecol; 1996 Jun; 87(6):943-7. PubMed ID: 8649703
[TBL] [Abstract][Full Text] [Related]
2. Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening.
Crossley JA; Aitken DA; Waugh SM; Kelly T; Connor JM
Prenat Diagn; 2002 Mar; 22(3):247-55. PubMed ID: 11920904
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
Hsu JJ; Hsieh TT; Soong YK; Spencer K
Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
[TBL] [Abstract][Full Text] [Related]
4. Total hCG versus free beta-hCG combined with alpha-fetoprotein for Down syndrome screening in Taiwan.
Hsieh TT; Hsu JJ; Cheng PJ; Lee CN; Jou HJ; Chen CP
Taiwan J Obstet Gynecol; 2007 Sep; 46(3):230-5. PubMed ID: 17962101
[TBL] [Abstract][Full Text] [Related]
5. Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk: result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population.
Chao AS; Chung CL; Wu CD; Chang SD; Cheng PJ; Lin YT; Soong YK
Acta Obstet Gynecol Scand; 1999 May; 78(5):393-7. PubMed ID: 10326883
[TBL] [Abstract][Full Text] [Related]
6. Prediction of adverse perinatal outcome by maternal serum screening for Down syndrome in an Asian population.
Hsieh TT; Hung TH; Hsu JJ; Shau WY; Su CW; Hsieh FJ
Obstet Gynecol; 1997 Jun; 89(6):937-40. PubMed ID: 9170469
[TBL] [Abstract][Full Text] [Related]
7. Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
Watt HC; Wald NJ; Smith D; Kennard A; Densem J
Prenat Diagn; 1996 Aug; 16(8):691-8. PubMed ID: 8878277
[TBL] [Abstract][Full Text] [Related]
8. The use of free beta-hCG in antenatal screening for Down's syndrome.
Wald N; Densem J; Stone R; Cheng R
Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18.
Chen Y; Chen Y; Ning W; Zhang W; Li L; Wang X; Yin Y; Zhang H
Sci Rep; 2022 Aug; 12(1):13605. PubMed ID: 35948592
[TBL] [Abstract][Full Text] [Related]
10. Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.
Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM
Prenat Diagn; 1995 Jun; 15(6):555-65. PubMed ID: 7544898
[TBL] [Abstract][Full Text] [Related]
11. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum screening for Down syndrome in a teaching hospital in Hong Kong.
Law L; Lau T; Fung T; Rogers MS; Hjelm M
Chin Med J (Engl); 1999 Aug; 112(8):754-7. PubMed ID: 11601289
[TBL] [Abstract][Full Text] [Related]
13. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
Talbot JA; Spencer K; Abushoufa RA
Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
[TBL] [Abstract][Full Text] [Related]
14. Comparison of second-trimester maternal serum free-beta-human chorionic gonadotropin and alpha-fetoprotein between normal singleton and twin pregnancies: a population-based study.
Zheng MM; Hu YL; Zhang CY; Ru T; Liu QL; Xu BY; Chen QG; Xu ZF; Zhang Y; Zhong XL
Chin Med J (Engl); 2010 Mar; 123(5):555-8. PubMed ID: 20367980
[TBL] [Abstract][Full Text] [Related]
15. Urine free beta-hCG and total estriol for Down syndrome screening during the second trimester in an Asian population.
Hsu JJ; Hsu TY; Hsieh TT; Soong YK; Hsieh FJ; Spencer K
Obstet Gynecol; 1999 Jul; 94(1):107-11. PubMed ID: 10389728
[TBL] [Abstract][Full Text] [Related]
16. Second-trimester double or triple screening for Down syndrome: a comparison of Chinese and Caucasian populations.
Wang YY; Luo J; Zhu MW; Liu LN; Ma X
Int J Gynaecol Obstet; 2006 Jul; 94(1):67-72. PubMed ID: 16806218
[TBL] [Abstract][Full Text] [Related]
17. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
Hu Z; Liu X; Li L; Jia C; Li D; Liu R
Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
[TBL] [Abstract][Full Text] [Related]
18. Elevated second-trimester maternal serum β-human chorionic gonadotropin and amniotic fluid alpha-fetoprotein as indicators of adverse obstetric outcomes in fetal Turner syndrome.
Alvarez-Nava F; Soto M; Lanes R; Pons H; Morales-Machin A; Bracho A
J Obstet Gynaecol Res; 2015 Dec; 41(12):1891-8. PubMed ID: 26369382
[TBL] [Abstract][Full Text] [Related]
19. Combining fetal nuchal fold thickness with second-trimester biochemistry to screen for trisomy 21.
Borrell A; Mercade I; Casals E; Borobio V; Seres A; Soler A; Fortuny A; Cuckle H
Ultrasound Obstet Gynecol; 2007 Dec; 30(7):941-5. PubMed ID: 18000942
[TBL] [Abstract][Full Text] [Related]
20. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
